249 related articles for article (PubMed ID: 2828693)
1. Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.
Rees-Jones RW; Goff SP
J Virol; 1988 Mar; 62(3):978-86. PubMed ID: 2828693
[TBL] [Abstract][Full Text] [Related]
2. Genome structure of Abelson murine leukemia virus variants: proviruses in fibroblasts and lymphoid cells.
Goff SP; Witte ON; Gilboa E; Rosenberg N; Baltimore D
J Virol; 1981 May; 38(2):460-8. PubMed ID: 6264122
[TBL] [Abstract][Full Text] [Related]
3. Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis.
Engelman A; Rosenberg N
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8021-5. PubMed ID: 2825174
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
Reddy EP; Smith MJ; Srinivasan A
Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
[TBL] [Abstract][Full Text] [Related]
5. A transformation-defective mutant of Abelson murine leukemia virus lacks protein kinase activity.
Witte ON; Goff S; Rosenberg N; Baltimore D
Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4993-7. PubMed ID: 6254050
[TBL] [Abstract][Full Text] [Related]
6. Abelson murine leukemia virus induces platelet-derived growth factor-independent fibroblast growth: correlation with kinase activity and dissociation from full morphologic transformation.
Rees-Jones RW; Goldfarb M; Goff SP
Mol Cell Biol; 1989 Jan; 9(1):278-87. PubMed ID: 2538721
[TBL] [Abstract][Full Text] [Related]
7. Structure and function of the Abelson murine leukemia virus transforming gene.
Wang JY; Prywes R; Baltimore D
Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
[TBL] [Abstract][Full Text] [Related]
8. Abelson murine leukemia virus mutants with alterations in the virus-specific P120 molecule.
Rosenberg N; Witte ON
J Virol; 1980 Jan; 33(1):340-8. PubMed ID: 6245237
[TBL] [Abstract][Full Text] [Related]
9. Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus.
Goff SP; Tabin CJ; Wang JY; Weinberg R; Baltimore D
J Virol; 1982 Jan; 41(1):271-85. PubMed ID: 6283119
[TBL] [Abstract][Full Text] [Related]
10. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
Engelman A; Rosenberg N
J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
[TBL] [Abstract][Full Text] [Related]
11. Retroviral insertional mutagenesis of a target allele in a heterozygous murine cell line.
Frankel W; Potter TA; Rosenberg N; Lenz J; Rajan TV
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6600-4. PubMed ID: 2995973
[TBL] [Abstract][Full Text] [Related]
12. Site-directed deletions of Abelson murine leukemia virus define 3' sequences essential for transformation and lethality.
Watanabe SM; Witte ON
J Virol; 1983 Mar; 45(3):1028-36. PubMed ID: 6300444
[TBL] [Abstract][Full Text] [Related]
13. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
14. Structure and origins of the HZ2-feline sarcoma virus.
Bergold PJ; Wang JY; Hardy WD; Littau V; Johnson E; Besmer P
Virology; 1987 Jun; 158(2):320-9. PubMed ID: 2884777
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of temperature-sensitive mutants of Abelson murine leukaemia virus that exhibit dissociation among morphological transformation, soft agar colony-forming ability and tyrosine kinase activity.
Oka Y; Sugiyama H; Tsukada S; Shimizu Y; Inoue H; Hakura A; Kishimoto S
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2527-32. PubMed ID: 2550581
[TBL] [Abstract][Full Text] [Related]
16. Abelson murine leukemia virus variants with increased oncogenic potential.
Murtagh K; Skladany G; Hoag J; Rosenberg N
J Virol; 1986 Nov; 60(2):599-606. PubMed ID: 3021994
[TBL] [Abstract][Full Text] [Related]
17. The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.
Daley GQ; McLaughlin J; Witte ON; Baltimore D
Science; 1987 Jul; 237(4814):532-5. PubMed ID: 2440107
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid sequence and oncogenic properties of the HZ2 feline sarcoma virus v-abl insert.
Bergold PJ; Blumenthal JA; D'Andrea E; Snyder HW; Lederman L; Silverstone A; Nguyen H; Besmer P
J Virol; 1987 Apr; 61(4):1193-202. PubMed ID: 3029415
[TBL] [Abstract][Full Text] [Related]
19. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro.
Watanabe SM; Rosenberg NE; Witte ON
J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787
[TBL] [Abstract][Full Text] [Related]
20. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.
Sadowski I; Stone JC; Pawson T
Mol Cell Biol; 1986 Dec; 6(12):4396-408. PubMed ID: 3025655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
